✦ LIBER ✦

Pulmonary hypertension in idiopathic pulmonary fibrosis: epidemiology, diagnosis and therapeutic implications

✍ Scribed by John Sherner, Jacob Collen, Christopher S. King, Steven D. Nathan

Book ID: 118304305
Publisher: Current Science Inc.
Year: 2012
Weight: 209 KB
Volume: 1
Category: Article
ISSN: 2161-332X
DOI: 10.1007/s13665-012-0027-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Idiopathic Pulmonary Fibrosis: Diagnosis

Idiopathic Pulmonary Fibrosis: Diagnosis and Epidemiology

✍ Olson, Amy L.; Swigris, Jeffrey J. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 242 KB

Idiopathic pulmonary fibrosis-related pu

Idiopathic pulmonary fibrosis-related pulmonary hypertension; an exercising diagnosis?

✍ Toby M. Maher; Athol U. Wells 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB

Prediction of pulmonary hypertension in

Prediction of pulmonary hypertension in idiopathic pulmonary fibrosis

✍ David A. Zisman; David J. Ross; John A. Belperio; Rajan Saggar; Joseph P. Lynch 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 192 KB

Therapeutic Update in Idiopathic Pulmona

Therapeutic Update in Idiopathic Pulmonary Fibrosis

✍ Andrew L. Chan, Rokhsara Rafii, Samuel Louie, Timothy E. Albertson 📂 Article 📅 2011 🏛 Humana Press Inc 🌐 English ⚖ 203 KB

IMAGING DIAGNOSIS—FELINE IDIOPATHIC PULM

IMAGING DIAGNOSIS—FELINE IDIOPATHIC PULMONARY FIBROSIS

✍ SCOTT A. SECREST; MICHAEL Q. BAILEY; KURT J. WILLIAMS; SEAN D. SMARICK 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 410 KB

Lung transplantation in scleroderma comp

Lung transplantation in scleroderma compared with idiopathic pulmonary fibrosis and idiopathic pulmonary arterial hypertension

✍ Lionel Schachna; Thomas A. Medsger Jr.; James H. Dauber; Fredrick M. Wigley; Nei 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 2 views

## Abstract ## Objective Lung transplantation is a viable, life‐saving intervention for several primary pulmonary disorders complicated by severe lung dysfunction. This study was undertaken to evaluate whether patients with systemic sclerosis (scleroderma), a systemic autoimmune rheumatic disorder